MaxCyte (MXCT) has released an update.
MaxCyte, Inc., a cell-engineering company specializing in platform technologies for cell-based therapies, will participate in the Craig-Hallum Capital Group Bioprocessing Conference virtually on September 19th. A replay of MaxCyte’s conference session will be accessible on their investor relations website. The company is known for its ExPERT platform, which supports the cell therapy market from research to commercialization.
For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.
